Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Thyroid Cancer Diagnostics Market Through 2034?

The market for thyroid cancer diagnosis has considerably expanded over past years. From $2.99 billion in 2024, it’s set to surge to $3.15 billion in 2025 with a compound annual growth rate (CAGR) of 5.5%. The impressive growth in the historic period is due to factors such as the increasing incidence of thyroid cancer, an aging populace, heightened awareness along with early detection, government backing and funding, and enhanced healthcare infrastructure.

The market size of thyroid cancer diagnostics is set to experience substantial growth in the upcoming years. By 2029, it’s forecasted to expand to$3.99 billion” at a CAGR of 6.1%. The predicted growth for this period is due to increased demand for companion diagnostics, a rise in patient inclination towards personalized medication, economic prosperity and healthcare expenditure, education and training for physicians, along with regulatory permissions and clearances. The anticipated trends for this period encompass liquid biopsies, internationalization of diagnostic technologies, advancements in technology, research, development, the incorporation of artificial intelligence, along with collaborations and partnerships.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12030&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Thyroid Cancer Diagnostics Market?

The rising incidences of thyroid cancer are contributing significantly to the expansion of the thyroid cancer diagnostic market. The condition manifests in the thyroid gland, located near the base of the throat, which generates hormones to regulate various bodily functions, including body temperature, heart rate, blood pressure, and weight. Diagnostics for thyroid cancer plays a critical role in its early detection, thereby enhancing the chances of successful treatment. Consequently, the growing number of thyroid cancer cases escalates the need for the diagnostic market. For instance, a study published by the American Cancer Society, a non-profit organization based in the US, predicts about 43,720 new thyroid cancer cases in September 2023 with 12,540 in men and 31,180 in women. The estimated death toll due to thyroid cancer in the same year is approximately 2,120, including 970 men and 1,150 women. Thus, the escalating occurrence of thyroid cancer is fueling the growth of the thyroid cancer diagnostic market.

Which Primary Segments of the Thyroid Cancer Diagnostics Market Are Driving Growth and Industry Transformations?

The thyroid cancer diagnosticsmarket covered in this report is segmented –

1) By Technique Type: Imaging Test; Blood Test; Biopsy; Other Test Type

2) By Disease Type: Papillary Carcinoma; Follicular Carcinoma; Other Diseases

3) By End-User: Hospital Laboratories; Cancer Diagnostic Centers; Research Institutes; Other End-Users

Subsegments:

1) By Imaging Test: Ultrasound Imaging; Computed Tomography (CT) Scans; Magnetic Resonance Imaging (MRI); Positron Emission Tomography (PET) Scans; Radioactive Iodine Scans

2) By Blood Test: Thyroid Function Tests; Tumor Marker Tests; Genetic Testing For Thyroid Cancer

3) By Biopsy: Fine Needle Aspiration (FNA) Biopsy; Core Needle Biopsy; Surgical Biopsy

4) By Other Test Type: Molecular Diagnostics; Immunohistochemistry Tests; Histopathological Analysis

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12030&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Thyroid Cancer Diagnostics Market?# Market?

North America was the largest region in the thyroid cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Thyroid Cancer Diagnostics Market?

Leading entities in the thyroid cancer diagnostic industry are revolutionizing their offerings by creating novel tools such as the RNA sequencing test to improve the precision of fusion detection in a wide array of solid tumors, including thyroid cancer. RNA sequencing (RNA-Seq) is a futuristic method that evaluates both the quantity and order of RNA in a sample, shedding light on gene expression and the complete transcriptome. For instance, in March 2024, Foundation Medicine, Inc, a biotech firm based in the United States, unveiled its latest offering in the U.S. – FoundationOne RNA. This variant of tissue-based RNA sequencing test is intended to identify cancer-associated gene fusions across 318 genes. This diagnostic tool generates fusion reports for all types of solid tumors and could be a potentially effective tool for detecting fusions in cancers like non-small cell lung cancer (NSCLC), sarcoma, pancreatic cancer, thyroid cancer, cholangiocarcinoma, and bladder cancer.

View the full report here:

https://www.thebusinessresearchcompany.com/report/thyroid-cancer-diagnostics-global-market-report

What Parameters Are Used to Define the Thyroid Cancer Diagnostics Market?

Thyroid cancer diagnostics refers to a technique to test a lump or nodule responsible for thyroid cancer present in the body and helps in diagnosing thyroid cancer. Thyroid cancer refers to a type of cancer that starts in the thyroid gland when cells begin to grow out of control.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12030

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model